Amgen (AMGN) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Amgen, as the data feed reports them.

Analysts' mean target, 29 analysts
$432.84
5.5% below the price

The 29 analysts reported by the data feed have a mean price target for Amgen of $432.84, 5.5% below the $457.93 price (range $230.00–$536.00). 2.33% of the float was sold short as of Oct 30, 2026. Institutions hold 84.7% of the shares and insiders 0.2%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$432.84−5.5% vs price
Analysts
29
Short interest
2.33%of float, Oct 30, 2026
Short ratio
4.71 days
Institutions
84.7%
Insiders
0.24%
Beta
0.42
Next earnings
Feb 2, 2027estimated

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

29 analysts covering Amgen, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $457.93.

Analysts' price targets for Amgen
Mean price target$432.845.5% below the price (−5.5%)
Median price target$440.003.9% below the price (−3.9%)
Highest target$536.0017.0% above the price (+17.0%)
Lowest target$230.0049.8% below the price (−49.8%)
Analysts with a target29

Ratings this month · 34 analysts

Strong buy 4(12%)Buy 7(21%)Hold 18(53%)Sell 3(9%)Strong sell 2(6%)
Analysts' ratings of Amgen this month, by rating
RatingAnalystsShare
Strong buy412%
Buy721%
Hold1853%
Sell39%
Strong sell26%

The feed averages these to 2.71 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “hold”.

Who owns Amgen

Ownership of Amgen
Held by institutions84.7%4,155 institutions; percent of shares outstanding
Held by institutions, of the float84.9%
Held by insiders0.24%percent of shares outstanding
Shares outstanding540.91M
Float539.44Mshares available to trade
Insiders' net purchases, six months+7.03K22 purchases (17.14K shares), 3 sales (10.11K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Amgen
Shares short12.59Mas of Oct 30, 2026
Percent of float2.33%shares short ÷ float
Percent of shares outstanding2.33%shares short ÷ shares outstanding
Short ratio (days to cover)4.71shares short ÷ average daily volume

Amgen short interest from FINRA, with its history

Trading figures

Trading figures for Amgen
Beta0.42movement against the market; 1 moves with it
52-week high$483.99
52-week low$312.39
Average volume, 3 months2.79Mshares a day
Average volume, 10 days2.7Mshares a day

Dates to know

Upcoming and recent dates for Amgen
Next earnings reportFeb 2, 2027the feed's estimate, not confirmed
Ex-dividend dateNov 20, 2026as the feed lists it
Dividend payment dateDec 11, 2026

Questions and answers

What is the analysts' price target for Amgen (AMGN)?

As reported by the data feed, the mean price target of the 29 analysts covering Amgen is $432.84, 5.5% below the latest price of $457.93. The highest target is $536.00 and the lowest $230.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Amgen stock?

Of the 34 ratings the data feed reports for the current month, 4 are strong buy, 7 buy, 18 hold, 3 sell and 2 strong sell.

How many Amgen shares are sold short?

As reported by the data feed, 12.59M shares were sold short, 2.33% of the float as of Oct 30, 2026. At the average daily volume that is 4.71 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Amgen stock?

As reported by the data feed, institutions hold 84.7% of the shares (4,155 institutions) and insiders 0.2%. There are 540.91M shares outstanding, of which 539.44M are in the float.

When is Amgen's next earnings report?

The data feed lists Feb 2, 2027, marked as its estimate rather than a date the company has confirmed. The latest ex-dividend date it lists is Nov 20, 2026.

How much does Amgen stock move with the market?

Its beta, as reported by the data feed, is 0.42: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $312.39 and $483.99.

Cite this page

Funkfolio, “Amgen (AMGN) statistics: analyst targets, short interest, ownership”, data as of 17 November 2026. https://funkfolio.com/stock/AMGN/statistics

Underlying data: Yahoo Finance.